The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_005026.5(PIK3CD):c.112C>T (p.Arg38Cys)

CA576774

657939 (ClinVar)

Gene: PIK3CD (HGNC:5293)
Condition: immunodeficiency 14 (MONDO:0014222)
Inheritance Mode: Autosomal dominant inheritance
UUID: f43a574e-777a-40a5-9b8b-4c470e1b761f
Approved on: 2025-12-19
Published on: 2025-12-23

HGVS expressions

NM_005026.5:c.112C>T
NM_005026.5(PIK3CD):c.112C>T (p.Arg38Cys)
NC_000001.11:g.9710567C>T
CM000663.2:g.9710567C>T
NC_000001.10:g.9770625C>T
CM000663.1:g.9770625C>T
NC_000001.9:g.9693212C>T
NG_023434.1:g.63836C>T
ENST00000481137.2:c.112C>T
ENST00000698706.1:n.363C>T
ENST00000698707.1:c.112C>T
ENST00000698708.1:n.320C>T
ENST00000698709.1:c.112C>T
ENST00000698710.1:c.112C>T
ENST00000698711.1:n.465C>T
ENST00000698712.1:c.112C>T
ENST00000698713.1:c.112C>T
ENST00000698714.1:c.112C>T
ENST00000698715.1:c.112C>T
ENST00000698716.1:c.112C>T
ENST00000377346.9:c.112C>T
ENST00000361110.6:c.112C>T
ENST00000377346.8:c.112C>T
ENST00000536656.5:c.112C>T
ENST00000543390.2:c.112C>T
ENST00000628140.2:c.112C>T
NM_005026.3:c.112C>T
NM_001350234.1:c.112C>T
NM_001350235.1:c.112C>T
NM_005026.4:c.112C>T
NM_001350234.2:c.112C>T
More

Likely Benign

Met criteria codes 1
BP4
Not Met criteria codes 3
BS1 PS4 PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Antibody Deficiencies Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for PIK3CD Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Antibody Deficiencies VCEP
NM_005026.5(PIK3CD):c.112C>T (p.Arg38Cys) is a missense variant causing replacement of arginine with cysteine at amino acid 38. This variant is present in gnomAD v4.1.0 at a total combined allele frequency of 0.00002358, with 37 alleles / 1,613,824 total alleles across all populations of gnomAD, which is higher than the ClinGen Antibody Deficiencies VCEP PM2_Supporting threshold of <0.00000132. The variant is present in gnomAD v.4.1.0 at a GrpMax allele frequency of 0.0002203, with 24 alleles / 74,832 total alleles in the African/African American population, which is lower than the BS1 threshold of >0.000316, so no population code can be applied. The computational predictor REVEL gives a score of 0.238, which is below the ClinGen Antibody Deficiencies VCEP threshold of <0.290 and predicts a non-damaging effect on PIK3CD function. The computational predictor CADD gives a PHRED score of 21.5, which is below the ClinGen Antibody Deficiencies VCEP threshold of <22.7 and predicts a non-deleterious effect on PIK3CD function. The two predictors agree on a non-damaging effect (BP4). In summary, this variant meets the criteria to be classified as likely benign for autosomal dominant immunodeficiency 14 based on the ACMG/AMP criteria applied, as specified by the ClinGen Antibody Deficiencies VCEP: BP4. (VCEP specifications version 1.0.0).
Met criteria codes
BP4
The computational predictor REVEL gives a score of 0.238, which is below the ClinGen Antibody Deficiencies VCEP threshold of <0.290 and predicts a non-damaging effect on PIK3CD function. The computational predictor CADD gives a PHRED score of 21.5, which is below the ClinGen Antibody Deficiencies VCEP threshold of <22.7 and predicts a non-deleterious effect on PIK3CD function. The two predictors agree on a non-damaging effect (BP4).
Not Met criteria codes
BS1
This variant is present in gnomAD v.4.1.0 at a GrpMax allele frequency of 0.0002203, with 24 alleles / 74,832 total alleles in the African/African American population, which is lower than the BS1 threshold of >0.000316, so no population code can be applied.
PS4
Reported in ClinVar by Ambry
PM2
This variant is present in gnomAD v4.1.0 at a total combined allele frequency of 0.00002358, with 37 alleles / 1,613,824 total alleles across all populations of gnomAD, which is higher than the ClinGen Antibody Deficiencies VCEP PM2_Supporting threshold of <0.00000132.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.